FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/070013 [Registered on: 04/07/2024] Trial Registered Prospectively
Last Modified On: 02/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To know and compare the shothhara karma - anti inflamatory activity of leaves and root of Agnimanth (Premna integrifolia Linn.) 
Scientific Title of Study   Evaluation of Shothahara Karma of leaves of Agnimantha (Premna integrifolia Linn.) as an alternative to its Root 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Nakum Banasree Damjibhai 
Designation  MD scholar 
Affiliation  Institute for post graduate teaching and research in Ayurveda Jamnagar 
Address  Department of Dravyaguna 3rd floor ITRA Jamnagar GUJARAT 361008 India Department of Dravyaguna 3rd floor ITRA Jamnagar GUJARAT 361008 India Jamnagar GUJARAT 361008 India

Jamnagar
GUJARAT
361008
India 
Phone  9974059893  
Fax    
Email  bansareenakum2212@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vd Bhupesh R Patel 
Designation  Professor and HOD 
Affiliation  Institute for post graduate teaching and research in Ayurveda Jamnagar 
Address  Department of Dravyaguna 3rd floor Room no 329 ITRA Jamnagar GUJRAT 361008 India Department of Dravyaguna 3rd floor Room no 329 ITRA Jamnagar GUJRAT 361008 India Jamnagar GUJARAT 361008 India

Jamnagar
GUJARAT
361008
India 
Phone  7487876343  
Fax    
Email  brpayu@itra.edu.in  
 
Details of Contact Person
Public Query
 
Name  Vd Bhupesh R Patel 
Designation  Professor and HOD 
Affiliation  Institute for post graduate teaching and research in Ayurveda Jamnagar 
Address  Department of Dravyaguna 3rd floor Room no 329 ITRA Jamnagar GUJRAT 361008 India Department of Dravyaguna 3rd floor Room no 329 ITRA Jamnagar GUJRAT 361008 India Jamnagar GUJARAT 361008 India

Jamnagar
GUJARAT
361008
India 
Phone  7487876343  
Fax    
Email  brpayu@itra.edu.in  
 
Source of Monetary or Material Support  
Institute of teaching and research in Ayurveda jamnagar Gujarat 361008 
 
Primary Sponsor  
Name  Institute of teaching and research in Ayurveda jamnagar 
Address  Institute of teaching and research in Ayurveda,Opposite reliance mart, jamnagar Gujarat 361008 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Nakum Banasree  PG Hospital institute of teaching and research in Ayurveda jamnagar Gujarat  OPD no A-1 PG hospital Dravyaguna,Institute of teaching and research in Ayurveda jamnagar Gujarat
Jamnagar
GUJARAT 
9974059893

bansareenakum2212@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee,Institute of teaching and research in ayurveda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:R609||Edema, unspecified. Ayurveda Condition: SVAYATHUH/SOTHAH/SOPAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Agnimanth moola churna, Reference: Bhavprakash guduchyadi varga, 24, Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: -ushnodak), Additional Information: -
2Intervention ArmDrugOther than Classical(1) Medicine Name: Agnimanth patra churna, Reference: NA, Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: -ushnodaka), Additional Information: -
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  1. Patients presenting with the classical signs and symptoms of Shotha with less than 3 months
Of chronicity.
2. Shotha due to hypothyroidism, generalized anasarca and hypoproteinaemia will be included
 
 
ExclusionCriteria 
Details  1.Patients suffering from any systemic uncontrolled disease like
Diabetes, hypertension, cardiac anomaly,
Chronic renal failure, Liver cirrhosis, filariasis, etc.
2.Pregnant or lactating mother.
3.Patients exhibiting lakshanas of aagantuj Shotha.
4.Patients suffering from any auto immune diseases. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
•Improvement in condition will be assessed based on changes in scoring patterns developed
for grading of these clinical factors on 0th and 14th day.
•Change in oedema pitting measurement of affected parts on0th and 14th day.
 
Out comes will be assessed on 0th and 14th day.
 
 
Secondary Outcome  
Outcome  TimePoints 
•Change in routine biochemistry, Blood and Urine investigations  On 0th and 14th day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This trial is randomized clinical trial to evaluate the efficacy of Agnimanth Patra Churna ( premna integrifolia Linn) in
compare to Agnimanth moola Churna in the management of Shotha. selected patients will be divided in to
two group on basis of computer generated randomization. in this study both the group will receive drug in dosage of 6g churna after food twice a day for 14 day. 

 
Close